- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 3 residues within 4Å:- Chain A: Y.96, N.98, T.100
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 4 residues within 4Å:- Chain A: Y.144, N.171, T.178, S.180
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain A: V.510, G.523, N.538
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 3 residues within 4Å:- Chain B: Y.96, N.98, T.100
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 4 residues within 4Å:- Chain B: Y.144, N.171, T.178, S.180
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 3 residues within 4Å:- Chain B: V.510, G.523, N.538
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 3 residues within 4Å:- Chain C: Y.96, N.98, T.100
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain C: Y.144, N.171, T.178, S.180
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 3 residues within 4Å:- Chain C: V.510, G.523, N.538
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 5 residues within 4Å:- Chain A: N.243, S.245, A.250, N.251, F.269
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 5 residues within 4Å:- Chain B: N.243, S.245, A.250, N.251, F.269
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 5 residues within 4Å:- Chain C: N.243, S.245, A.250, N.251, F.269
No protein-ligand interaction detected (PLIP)- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: N.147, N.148
Ligand excluded by PLIPNAG.17: 6 residues within 4Å:- Chain A: R.129, G.130, T.131, L.133, N.220, T.222
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: Y.305, N.326, T.328
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.440
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.464
- Chain B: S.720
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.518
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.542
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.663, S.665
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.671
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.714, K.717
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: Q.821, N.930
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.147, N.148
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain B: R.129, G.130, T.131, L.133, N.220, T.222
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: Y.305, N.326, T.328
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.440
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.464
- Chain C: S.720
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.518
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.542
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.663, S.665
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.671
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.714, K.717
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: Q.821, N.930
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: N.147, N.148
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain C: R.129, G.130, T.131, L.133, N.220, T.222
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: Y.305, N.326, T.328
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.440
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain A: S.720
- Chain C: N.464
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.518
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.542
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.663, S.665
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.671
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.714, K.717
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: Q.821, N.930
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Z. et al., The human coronavirus HCoV-229E S-protein structure and receptor binding. Elife (2019)
- Release Date
- 2019-11-13
- Peptides
- spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Z. et al., The human coronavirus HCoV-229E S-protein structure and receptor binding. Elife (2019)
- Release Date
- 2019-11-13
- Peptides
- spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C